Faculty Educator and Planning Committee Disclosures

This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the
FDA. Academy and ACTHIV do not recommend the use of any agent outside of the labeled indications. Faculty will disclose
such discussion at the time of their sessions.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy, or
ACTHIV. This educational activity is intended as a supplement to existing knowledge, published information, and practice
guidelines. Learners should appraise the information presented critically and draw conclusions only after careful
consideration of all available scientific information.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other
individuals who are in a position to control content are required to disclose any relationships with any ineligible
company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity.
Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships
listed for these individuals have been mitigated.

Faculty Educator Disclosures

The following individuals have no relevant financial relationships with ineligible companies to disclose:
Wendy Armstrong, MD
Oni Blackstock, MD, MHS
Alexandra Canetti, MD
Suzanne Carlberg-Racich, MSPH, PhD
Lisa Catalli, MSN, NP-C
Grant Ellsworth, MD, MS
Latesha Elopre, MD, MSPH
Rajesh Gandhi, MD
Grissel Granados, MSW
Vincent Guilamo-Ramos, PhD, MPH,
LCSW, RN, ANP-BC, PMHNP-BC,
AAHIVS, FAAN
Minh Ho, DO
Jennifer Kay-Berene Klein, MSN
Tiommi Luckett, Associate of Arts
Diana C Martins-Welch, MD
Toby A Maurer, MD
Amesika Nyaku, MD, MS
Maxwell Parrish, CRNP
Virginia Athena Triant, MD, MPH

The following individuals have relevant financial relationships with ineligible companies to disclose:

Frederick L Altice, MD, MA: Advisory Board/Consultant – Gilead Sciences, Merck, AbbVie, Bristol Myers Squibb*;
Grant/Research Support – Merck, Gilead Sciences, Gilead Foundation*; Speaker’s Bureau – Gilead Sciences, Merck, Bristol
Myers Squibb*
Dawn Averitt, BIS: Advisory Board/Consultant – Merck, Gilead Sciences, ViiV Healthcare
Rachel Ann Bender Ignacio, MD, MPH: Advisory Board/Consultant – AbbVie, Resverlogix, SeaGen*; Grant/Research Support
– Novartis
Meredith Edwards Clement, MD: Advisory Board/Consultant – ViiV Healthcare* Grant/Research Support – Gilead Sciences,
ViiV Healthcare
Jennifer Cocohoba, PharmD, MAS: Grant/Research Support – ViiV Healthcare
Oluwaseun Falade-Nwulia, MBBS, MPH: Advisory Board/Consultant – Gilead Sciences; Grant/Research Support: AbbVie
George Froehle, PA-C: Advisory Board/Consultant – Gilead Sciences
Nina Kim, MD, MSc: Grant/Research Support – Gilead Sciences
Jennifer Price, MD, PhD: Advisory Board/Consultant – Theratechnologies, Gilead Sciences, Merck; Grant/Research Support –
Gilead Sciences, Merck; Speaker’s Bureau – Gilead Sciences
Sharon Riddler, MD, MPH: Grant/Research Support – Gilead Sciences, Merck

Renslow Sherer MD: Grant/Research Support – Gilead Sciences
William R Short, MD, MPH, FIDSA: Advisory Board/Consultant – Gilead Sciences, ViiV Healthcare; Speaker’s Bureau – ViiV
Healthcare, Janssen
Eugenia L Siegler, MD: Grant/Research Support – Gilead Sciences*
Sarita Sonalkar, MD, MPH: Grant/Research Support – Evofem Pharmaceuticals, Myovant Pharmaceuticals
Richard K Sterling, MD, MSc: Grant/Research Support – Roche, Abbott, AbbVie, Gilead Sciences; Other Relationship – Pfizer:
DSMB, AskBio: DSMB
Karen Tashima, MD: Grant/Research Support – Merck, GlaxoSmithKline/ViiV Healthcare, Gilead Sciences
Jeff Taylor: Advisory Board/Consultant – Gilead Sciences; Grant/Research Support – Merck
Susan Tuddenham, MD, MPH: Advisory Board/Consultant – Luca Biologics*, Roche Molecular Diagnostics*
*Indicates relationship has ended

Conference Planning Committee and Session Co-Chair Disclosures

The following individuals have no relevant financial relationships with ineligible companies to disclose:
Beatrice Aladin, MD, MPA
Jillian Baron, MD, MPH
John T Brooks, MD
Jose Castillo-Mancilla, MD**
Lisa Catalli, MSN, NP-C
Jonathan Colasanti, MD, MSPH**
Sherrillyn Crooks, PA-C
Christopher Evans, MD
Courtney V Fletcher, PharmD**
Donna Futterman, MD
Rajesh Gandhi, MD**
Mary Glenshaw, PhD, MPH, OTR/L
Jose Gutierrez, PhD, MSN, FNP-BC
Tomasz Jodlowski, PharmD**
John JD Juchniewicz, MCIS, CHCP,
FACEHP
Natalie Kirkwood, RN, BSN, JD
Jennifer Kay-Berene Klein, MSN
Harry Lampiris, MD**
Sharon Lee, MD
Vincent Lo Re, MD, MSCE**
Amber McCracken
Lorenzo McFarland, DHA, MPH,
MSW, PMP
Paul Miniter, MS
Edward Moylan, RP
Asa Radix, MD, PhD, MPH**
Dianne Rausch, PhD**
Aaron Richterman, MD MPH
Jeri (Jieri) Sumitani, MMSc, PA-C
Pablo Tebas, MD
Ronald Dean Wilcox MD
Darcy Wooten, MD, MS

The following individuals have relevant financial relationships with ineligible companies to disclose:

Dawn Averitt, BIS: Advisory Board/Consultant – Merck, Gilead Sciences, ViiV Healthcare
Roger Bedimo, MD, MS: Advisory Board/Consultant – Merck, ViiV Healthcare, Theratechnologies*
Eric Daar, MD**: Advisory Board/Consultant – Merck, Gilead Sciences, ViiV Healthcare; Grant/Research Support – Gilead
Sciences, ViiV Healthcare
Carlos del Rio, MD: Advisory Board/Consultant: Resverolix, Sanofi-Pasteur*
Margaret Hoffman-Terry, MD, FACP, AAHIVS: Advisory Board/Consultant – ViiV Healthcare; Grant/Research Support – ViiV
Healthcare; Speakers Bureau – Gilead Sciences, ViiV Healthcare
H. Nina Kim, MD, MSc**: Grant/Research Support – Gilead Sciences
Igho Ofotokun, MD, MSc**: Grant/Research Support – Merck
Tonia Poteat, PhD, MPH, PA-C**: Advisory Board/Consultant – Merck, ViiV Healthcare
Jennifer Price, MD, PhD**: Advisory Board/Consultant – Theratechnologies, Gilead Sciences, Merck; Grant/Research Support
– Gilead Sciences, Merck; Speaker’s Bureau – Gilead Sciences
Jason Schafer, PharmD, MPH: Advisory Board/Consultant – Merck, ViiV Healthcare; Grant/Research Support – Merck, Gilead
Sciences*
Renslow Sherer MD**: Grant/Research Support – Gilead Sciences
William R Short, MD, MPH, FIDSA**: Advisory Board/Consultant – Gilead Sciences, ViiV Healthcare; Speaker’s Bureau – ViiV
Healthcare, Janssen
Babaafemi Taiwo, MBBS**: Advisory Board/Consultant – Gilead Sciences, Merck, ViiV Healthcare, Janssen
Melanie Thompson, MD**: Grant/Research Support – Cepheid Inc, Cytodyn Inc, Frontier Biotechnologies, Gilead Sciences,
GlaxoSmithKline, Merck, ViiV Healthcare
Andrea Weddle, MSW: Policy Consultation: Merck
Susan Weiss, FNP-BC, MSN, AAHIVS: Advisory Board* – Gilead Sciences, Merck, ViiV Healthcare, Janssen; Speaker’s Bureau*
– Gilead Sciences, ViiV Healthcare, Janssen

*Indicates relationship has ended
**indicates Session Cochair